Literature DB >> 31655169

Five decades of urologic pathology: the accelerating expansion of knowledge in renal cell neoplasia.

Gregory T MacLennan1, Liang Cheng2.   

Abstract

Those who are knowledgeable in cosmology inform us that the expansion of the universe is such that the velocity at which a distant galaxy is receding from the observer is continually increasing with time. We humbly paraphrase that as "The bigger the universe gets, the faster it gets bigger." This is an interesting analogy for the expansion of knowledge in the field of renal tumor pathology over the past 30 to 50 years. It is clear that a multitude of dedicated investigators have devoted incalculable amounts of time and effort to the pursuit of knowledge about renal epithelial neoplasms. As a consequence of the contributions of numerous investigators over many decades, the most recent World Health Organization classification of renal neoplasms includes about 50 well defined and distinctive renal tumors, as well as various miscellaneous and metastatic tumors. In addition, a number of emerging or provisional new entities are under active investigation and may be included in future classifications. In this review, we will focus on a number of these tumors, tracing as accurately as we can the origins of their discovery, relating relevant additions to the overall knowledge base surrounding them, and in some instances addressing changes in nomenclature.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Classification; Emerging new entity; History; Kidney; Renal tumors

Year:  2019        PMID: 31655169     DOI: 10.1016/j.humpath.2019.09.009

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  5 in total

1.  Obituary Prof. Ondrej Hes.

Authors:  Maurizio Colecchia
Journal:  Virchows Arch       Date:  2022-10-19       Impact factor: 4.535

Review 2.  Systemic Therapies for the Management of Non-Clear Cell Renal Cell Carcinoma: What Works, What Doesn't, and What the Future Holds.

Authors:  Panagiotis Zoumpourlis; Giannicola Genovese; Nizar M Tannir; Pavlos Msaouel
Journal:  Clin Genitourin Cancer       Date:  2020-12-02       Impact factor: 2.872

Review 3.  Towards a new WHO classification of renal cell tumor: what the clinician needs to know-a narrative review.

Authors:  Alessia Cimadamore; Liang Cheng; Marina Scarpelli; Francesco Massari; Veronica Mollica; Matteo Santoni; Antonio Lopez-Beltran; Rodolfo Montironi; Holger Moch
Journal:  Transl Androl Urol       Date:  2021-03

Review 4.  Chromophobe renal cell carcinoma: Novel molecular insights and clinicopathologic updates.

Authors:  Reza Alaghehbandan; Christopher G Przybycin; Virginie Verkarre; Rohit Mehra
Journal:  Asian J Urol       Date:  2021-12-01

5.  Computational analysis of pathological images enables a better diagnosis of TFE3 Xp11.2 translocation renal cell carcinoma.

Authors:  Jun Cheng; Zhi Han; Rohit Mehra; Wei Shao; Michael Cheng; Qianjin Feng; Dong Ni; Kun Huang; Liang Cheng; Jie Zhang
Journal:  Nat Commun       Date:  2020-04-14       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.